EuroVacc’s primary objectives

icon-aidsPromote vaccine research
To promote vaccine research against HIV and other infectious diseases by bridging the strength of academic research groups with industrial expertise

icon-crossFacilitate and support phase I & II clinical trials in Europe
To facilitate and support phase I & II clinical trials in Europe to expedite translational research from discovery to clinical development;

icon-earthPartner with other international initiative
To partner with other international initiatives and industry for down-stream development and phase IIb/III trials.

Development of safe and effective HIV vaccines

EuroVacc is a non-profit organization dedicated to the development of safe and effective vaccines against HIV and other infectious diseases, through promoting and fostering collaborations with world leading vaccine researchers and developers in both public and private sectors.

Scientific Program

The primary focus of EVF's scientific program is on facilitating translational research from discovery to early phase I/II clinical development. EVF has successfully supported the development of a number of HIV vaccine candidates from bench to clinic. More recently, EVF is expanding its portfolio to other infectious disease areas through providing scientific project management support to large research consortia with the focus on facilitating the development from bench to clinic. To this end, EVF engages a pool of experts from manufacturing, to regulatory to clinical trials.